Combination treatment with donor-specific transfusions and cyclosporine A induces long-term survival of cardiac allografts in miniature swine

Transplantation

Volumn 80, Issue 9, 2005, Pages 1275-1282

  Hoerbelt, Ruediger ^a   Johnston, Douglas R ^a   Shoji, Tsuyoshi ^a   Houser, Stuart L ^a   Hasse, Rebecca S ^a   Ledgerwood, Levi G ^a   Iribarne, Alexander ^a   Allan, James S ^a   Sayegh, Mohamed H ^b   Sachs, David H ^a   Madsen, Joren C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cyclosporine A; Donor specific transfusion; Heart; Heart transplantation; Miniature swine; Tolerance

Indexed keywords

ANTIBODY; ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC GRAFT REJECTION; CELL PROLIFERATION; CONTROLLED STUDY; GRAFT SURVIVAL; MONONUCLEAR CELL; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; SURVIVAL TIME; SWINE; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; APOPTOSIS; BLOOD TRANSFUSION; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CORONARY VESSELS; CYCLOSPORINE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; SWINE; SWINE, MINIATURE; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 28544445588     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000177638.56260.23     Document Type: Article

References (44)

1. Soulillou JP. Donor-specific transfusion-induced tolerance: mechanisms revisited. Transplant Proc 1998; 30: 2438-2440.
2. Leonard AA, Jonker M, Lagaaij EL. Complete withdrawal of immunosuppression in allograft recipients. A study in rhesus monkeys. Transplantation 1996; 61: 1648-1651.
3. Rosengard BR, Ojikutu CA, Guzzetta PC, et al. Induction of specific tolerance to class I disparate renal allografts in miniature swine with cyclosporine. Transplantation 1992; 54: 490-497.
4. Madsen JC, Sachs DH, Fallon JT, Weissman NJ. Cardiac allograft vasculopathy in partially inbred miniature swine.I.Time course, pathology, and dependence on immune mechanisms. J Thorac Cardiovasc Surg 1996; 111: 1230-1239.
5. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256-262.
6. Kawai T, Cosimi AB, Wee SL, et al. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation 2002; 73: 1757-1764.
7. Pennington LR, Lunney JK, Sachs DH. Transplantation in miniature swine. VIII. Recombination within the major histocompatibility complex of miniature swine. Transplantation 1981; 31: 66-71.
8. Madsen JC. Cardiac allograft vasculopathy in miniature swine: Utility of a large animal model. Graft 1998; 1 (suppl II): 41-44.
9. Huang CA, Lort T, Arn JS, et al. Characterization of a monoclonal anti-porcine CD3 antibody. Xenotransplantation 1999; 6: 201-212.
10. Pescovitz MD, Lunney JK, Sachs DH. Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J Immunol 1984; 133: 368-375.
11. Lee RS, Yamada K, Womer KL, et al. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses. J Immunol 2000; 164: 3434-3444.
12. Yamada K, Mawulawde K, Menard MT, et al. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: The effect of augmentation of donor antigen load. J Thorac Cardiovasc Surg 2000; 119: 709-719.
13. Billingham ME, Cary NR, Hammond ME, et al. A working formulation tor the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transpl 1990; 9: 587-593.
14. Lurie KG, Billingham ME, Jamieson SW, et al. Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. Transplantation 1981; 31: 41-47.
15. Yang L, Du TB, Khan Q, Zhang L. Mechanisms of long-term donorspecific allograft survival induced by pretransplant infusion of lymphocytes. Blood 1998; 91: 324-330.
16. Douillard P, Pannetier C, Josien R, et al. Donor-specific blood transfusion-induced tolerance in adult rats with a dominant TCR-Vbeta rearrangement in heart allografts. J Immunol 1996; 157: 1250-1260.
17. Saitovitch D, Bushell A, Mabbs DW, et al. Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness. Transplantation 1996; 61: 1642-1647.
18. Madsen JC, Yamada K, Allan JS, et al. Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine. Transplantation 1998; 65: 304-313.
19. Li Y, Li XC, Zheng XX, et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999; 5: 1298-1302.
20. Wells AD, Li XC, Li Y, et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 5: 1303-1307.
21. Kurtz J, Lie A, Griffith M, et al. Lack of role for CsA-sensitive or Fas pathways in the tolerization of CD4 T cells via BMT and anti-CD40L. Am J Transplant 2003; 3: 804-816.
22. Fuchimoto Y, Huang C, Shimizu A, et al. An allelic non-histocompatibility antigen with wide tissue distribution as a marker for chimerism in pigs. Tissue Antigens 1999; 54: 43-52.
23. Opelz G, Vanrenterghem Y, Kirste G, et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997; 63: 964-967.
24. Grailer AP, Sollinger HW, Kawamura T, Burlingham WJ. Donor-specific cytotoxic T lymphocyte hyporesponsiveness following renal transplantation in patients pretreated with donor-specific transfusions. Transplantation 1991; 51: 320-324.
25. van der Mast BJ, Balk AH. Effect of HLA-DR-shared blood transfusion on the clinical outcome of heart transplantation. Transplantation 1997; 63: 1514-1519.
26. Sachs DH. MHC Homozygous Miniature Swine. In: Swindle, MM, Moody DC, Phillips LD, eds. Swine as Models in Biomedical Research. Ames: Iowa State University Press, 1992: 3-15.
27. Bushell A, Pearson TC, Morris PJ, Wood KJ. Donor-Recipient Microchimerism Is Not Required For Tolerance Induction Following Recipient Pretreatment With Donor-Specific Transfusion and Anti-CD4 Antibody. Transplantation 1995; 59: 1367-1371.
28. Josien R, Pannetier C, Douillard P, et al. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. Transplantation 1995; 60: 1131-1139.
29. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med 1987; 165: 566-571.
30. Armstrong HE, Bolton EM, McMillan I, et al. Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens. J Exp Med 1987; 165: 891-907.
31. Josien R, Douillard P, Guillot C, et al. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest 1998; 102: 1920-1926.
32. Dahmen U, Qian S, Rao AS, et al. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation 1994; 58: 1-8.
33. Bugeon L, Cuturi MC, Paineau J, et al. Similar levels of granzyme A and perforin mRNA expression in rejected and tolerated heart allografts in donor-specific tolerance in rats. Transplantation 1993; 56: 405-408.
34. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med 1987; 165: 566-571.
35. Josien R, Muschen M, Gilbert E, et al. Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance. Transplantation 1998; 66: 887-893.
36. Koshiba T, Kitade H, Van Damme B, et al. Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation 2003; 76: 588-596.
37. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998; 280: 243-248.
38. Bojakowski K, Religa P, Bojakowski M, et al. Arteriosclerosis in rat aortic allografts: Early changes in endothelial integrity and smooth mucle phenotype. Transplantation 2000; 70: 65-72.
39. Russell PS, Chase CM, Sykes M, et al. Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 2001; 167: 5731-5740.
40. Fedoseyeva EV, Zhang F, Orr PL, et al. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 1999; 162: 6836-6842.
41. Tellides G, Tereb DA, Kirkiles-Smith NC, et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000; 403: 201-211.
42. Salvatierra Jr., O, Vincenti, F, Amend W, et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 1980; 192: 543-552.
43. Soulillou JP, Blandin F, Gunther E, Lemoine V. Genetics of the blood transfusion effect on heart allografts in rats. Transplantation 1984; 38: 63-67.
44. Lee RS, Yamada K, Houser SL, et al. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc Natl Acad Sci U S A 2001; 98: 3276-3281.